AU748838B2 - Composition for the treatement of immune deficiencies and methods for its preparation and use - Google Patents

Composition for the treatement of immune deficiencies and methods for its preparation and use Download PDF

Info

Publication number
AU748838B2
AU748838B2 AU47734/99A AU4773499A AU748838B2 AU 748838 B2 AU748838 B2 AU 748838B2 AU 47734/99 A AU47734/99 A AU 47734/99A AU 4773499 A AU4773499 A AU 4773499A AU 748838 B2 AU748838 B2 AU 748838B2
Authority
AU
Australia
Prior art keywords
afp
aap
complex according
reversible complex
equilibrium reversible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU47734/99A
Other languages
English (en)
Other versions
AU4773499A (en
Inventor
Oleg Strelchenok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ardenia Investments Ltd
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Publication of AU4773499A publication Critical patent/AU4773499A/en
Application granted granted Critical
Publication of AU748838B2 publication Critical patent/AU748838B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU47734/99A 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use Ceased AU748838B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802162 1998-06-17
SE9802162A SE9802162D0 (sv) 1998-06-17 1998-06-17 Immunostimulating composition
PCT/EP1999/004201 WO1999065936A2 (en) 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use

Publications (2)

Publication Number Publication Date
AU4773499A AU4773499A (en) 2000-01-05
AU748838B2 true AU748838B2 (en) 2002-06-13

Family

ID=20411743

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47734/99A Ceased AU748838B2 (en) 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use

Country Status (10)

Country Link
US (1) US6599507B2 (enExample)
EP (1) EP1085909B1 (enExample)
JP (1) JP4392991B2 (enExample)
AT (1) ATE314094T1 (enExample)
AU (1) AU748838B2 (enExample)
BR (1) BR9911294B1 (enExample)
CA (1) CA2335079C (enExample)
DE (1) DE69929189T2 (enExample)
SE (1) SE9802162D0 (enExample)
WO (1) WO1999065936A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition
SE9900941D0 (sv) * 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
JP4515642B2 (ja) * 1999-03-16 2010-08-04 アーデニア・インベストメンツ・リミテッド 多価不飽和脂肪酸誘導体およびその使用
ATE339429T1 (de) * 2000-07-12 2006-10-15 Ardenia Investments Ltd Neue cytotoxische verbindungen und deren verwendung
US20070111936A1 (en) * 2005-11-15 2007-05-17 Vladimir Pak Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition

Also Published As

Publication number Publication date
HK1035866A1 (en) 2001-12-14
JP2004500315A (ja) 2004-01-08
BR9911294A (pt) 2002-01-02
US20010034324A1 (en) 2001-10-25
SE9802162D0 (sv) 1998-06-17
EP1085909A2 (en) 2001-03-28
DE69929189T2 (de) 2006-08-31
JP4392991B2 (ja) 2010-01-06
AU4773499A (en) 2000-01-05
US6599507B2 (en) 2003-07-29
WO1999065936A3 (en) 2000-02-10
BR9911294B1 (pt) 2012-01-10
EP1085909B1 (en) 2005-12-28
WO1999065936A2 (en) 1999-12-23
CA2335079A1 (en) 1999-12-23
ATE314094T1 (de) 2006-01-15
CA2335079C (en) 2008-01-08
DE69929189D1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
Weinstein et al. Membranes of animal cells: VI. The glycolipids of the L cell and its surface membrane
Parker et al. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood
Hui et al. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
CA2215339C (en) Immunomodulating compositions from bile for the treatment of immune system disorders
EP0717631B1 (en) Immunomodulating compositions from bile
Stein et al. Chloroquine-induced interference with degradation of serum lipoproteins in rat liver, studied in vivo and in vitro
Wilkinson Inhibition of leukocyte locomotion and chemotaxis by lipid-specific bacterial toxins
EP1085909B1 (en) A complex of alpha-fetoprotein (AFP) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies
US4167557A (en) Ubiquitous immunopoietic polypeptide (UBIP) and methods
US6403554B2 (en) Polyunsaturated fatty acid derivatives and their use
Bouma et al. Synthesis and secretion of lipoproteins by human hepatocytes in culture
US4129648A (en) Method for reducing endogenous prostaglandin synthesis
RU2205010C2 (ru) Природные противоопухолевые или противовирусные вещества и их применение
Bodenheimer Jr et al. Characterization of a new monoclonal antibody to rat macrophages and Kupffer cells
US20040101569A1 (en) Immunomodulating compositions from bile
JPS63246339A (ja) 親油性有効成分のリポタンパク質への取り込み方法、そのリポタンパク質および医薬組成物
HK1035866B (en) A complex of alpha-fetoprotein (afp) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies
Rebbaa et al. Distribution of exogenously added gangliosides in serum proteins depends on the relative affinity of albumin and lipoproteins.
Yamashita et al. Intestinal absorption and urinary excretion of antitumor peptidomannan KS-2 after oral administration in rats
KR910004574B1 (ko) 프럭토즈 1,6-디포스페이트를 함유하는 리포좀의 제조방법
Subbiah Newly recognized lipid carrier proteins in fetal life
MXPA00012558A (en) Composition for the treatement of immune deficiencies and methods for its preparation and use
Bullier-Picard et al. In-vivo uptake of human growth hormone in male rat liver
Portman et al. Influence of lysophosphatidylcholine on the metabolism of plasma lipoproteins
US20070219126A1 (en) Class of bioactive glycoprotein

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)